Preparation and pharmacodynamic evaluation of liposomes of indomethacin

Drug Development and Industrial Pharmacy

Volumn 26, Issue 3, 2000, Pages 313-321

  Srinath, P ^a   Vyas, S P ^b   Diwan, Prakash V ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Anti inflammatory; Encapsulation efficiency; Liposomes; Ulcer index

Indexed keywords

CARRAGEENAN; CHOLESTEROL; FREUND ADJUVANT; INDOMETACIN; LIPOSOME; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; ENCAPSULATION; HUMAN; KIDNEY DISEASE; LIPID COMPOSITION; MALE; NEUROTOXICITY; NONHUMAN; PAW EDEMA; PHARMACODYNAMICS; PHOSPHOLIPID VESICLE; RAT; RHEUMATOID ARTHRITIS; SLOW DRUG RELEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; EDEMA; INDOMETHACIN; LIPOSOMES; MALE; RATS; RATS, WISTAR; STOMACH ULCER;

EID: 0034123971     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100100359     Document Type: Article

References (9)

1. P. A. Insel, in The Pharmacological Basis of Therapeutics, Maxwell Macmillan International ed., Pergamon, New York, 1990, p. 659.
2. M. Simionescu, Ciba Found. Symp., 71 (1980).
3. I. H. Shaw, C. G. Knight, D. P. Page Thomas, N. C. Phillips, and J. Dingle, Br. J. Exp. Pathol., 60, 142 (1979).
4. S. C. Davis, R. P. Howard, and M. McHarden, Biochim. Biophys. Acta, 649, 129 (1981).
5. S. Perrett, M. Golding, and P. Williams, J. Pharm. Pharmacol., 43, 154 (1991).
6. P. Miquel, L. Monica, G. Monstserrat, F. Joan, and E. Joan, Chem. Pharm. Bull., 43, 983 (1995).
7. J. C. M. Stewart, Anal. Biochem., 104, 10 (1980).
8. Ch. A. Winter, E. A. Rissley, and G. W. Nuss, Proc. Soc. Exp. Biol. Med., 111, 544 (1962).
9. A. Robert, J. E. Nezamis, C. Lancaster, and A. Hanchar, Gastroenterology, 77, 433 (1979).